A Novel Injectable Formulation of Diclofenac Compared with Intravenous Ketorolac or Placebo for Acute Moderate-to-Severe Pain After Abdominal or Pelvic Surgery

医学 双氯芬酸 酮咯酸 麻醉 安慰剂 双氯芬酸钠 酮咯酸氨丁三醇 丸(消化) 可视模拟标度 恶心 止痛药 外科 药理学 病理 替代医学
作者
Tong J. Gan,Stephen E. Daniels,Neil Singla,Douglas A. Hamilton,Daniel B. Carr
出处
期刊:Anesthesia & Analgesia [Lippincott Williams & Wilkins]
卷期号:115 (5): 1212-1220 被引量:40
标识
DOI:10.1213/ane.0b013e3182691bf9
摘要

Injectable formulations of diclofenac have long been available in Europe and other countries. These formulations use a default dose of 75 mg of diclofenac delivered IV over 30 to 120 minutes or as an IM injection. A novel formulation of injectable diclofenac sodium, Dyloject®, is solubilized with hydroxypropyl β-cyclodextrin (HPβCD) so that it can be given IV or IM in a small volume bolus. In this multicenter, multiple-dose, multiple-day, randomized, double-blind, parallel-group phase 3 study, we investigated whether lower doses of HPβCD diclofenac delivered as a small volume bolus would be effective for the management of acute pain after abdominal or pelvic surgery.Adults with moderate and severe pain, defined as ≥50 mm on a 0 to 100 mm visual analog scale, within 6 hours after surgery were randomly assigned (1:1:1:1 ratio) to receive HPβCD diclofenac, 18.75 mg or 37.5 mg; ketorolac tromethamine 30 mg; or placebo. Patients in all treatment arms received a bolus IV injection every 6 hours until discharged. They were observed for at least 48 h, and for up to 5 days. Rescue IV morphine was available any time, up to a total of 7.5 mg over a 3-hour period. The primary efficacy measure was the sum of pain intensity differences from 0 to 48 hours after study drug initiation.Three hundred thirty-one patients received ≥1 dose of study drug. Over the first 48 hours, both IV HPβCD diclofenac doses, as well as ketorolac, produced significant reductions in pain intensity over placebo (all P < 0.05), as well as significant reductions in the need for rescue morphine administration. Both doses of HPβCD diclofenac, as well as ketorolac, significantly reduced rescue morphine dosages, as compared to placebo (P < 0.0001), and time to rescue morphine administration was significantly increased by treatment with 18.75 mg diclofenac and ketorolac. The overall incidence of treatment-related adverse events was 20.2%. No treatment-related serious adverse events were reported in either diclofenac dose group, whereas only 1 was reported in the ketorolac group.For patients with acute moderate and severe pain after abdominal or pelvic surgery, repeated 18.75 mg and 37.5 mg doses of HPβCD diclofenac provided significant analgesic efficacy, as compared to placebo. Significant analgesic efficacy was also provided by the active comparator ketorolac. Both HPβCD diclofenac and ketorolac significantly reduced the need for opioids.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CL完成签到,获得积分10
1秒前
1秒前
研友_Zzrx6Z完成签到,获得积分10
2秒前
2秒前
浮熙完成签到 ,获得积分10
2秒前
3秒前
DE完成签到,获得积分10
3秒前
4秒前
情怀应助科研通管家采纳,获得10
4秒前
11ran应助科研通管家采纳,获得10
4秒前
田様应助科研通管家采纳,获得10
4秒前
顾矜应助科研通管家采纳,获得10
5秒前
大个应助22222采纳,获得10
5秒前
5秒前
tramp应助科研通管家采纳,获得10
5秒前
Jasper应助喵了个咪采纳,获得10
5秒前
所所应助科研通管家采纳,获得10
5秒前
科研通AI5应助科研通管家采纳,获得10
5秒前
Akim应助科研通管家采纳,获得10
5秒前
许甜甜鸭应助科研通管家采纳,获得10
5秒前
斯文败类应助科研通管家采纳,获得10
5秒前
可可应助科研通管家采纳,获得10
5秒前
英俊的铭应助科研通管家采纳,获得20
6秒前
李健应助科研通管家采纳,获得10
6秒前
6秒前
Li应助科研通管家采纳,获得10
6秒前
6秒前
852应助科研通管家采纳,获得10
6秒前
llyy487发布了新的文献求助30
6秒前
所所应助科研通管家采纳,获得10
6秒前
7秒前
Yxs发布了新的文献求助10
7秒前
洪洪完成签到,获得积分20
7秒前
无花果应助lonely陈采纳,获得10
8秒前
彭于晏应助李善聪采纳,获得10
8秒前
不辣的皮特完成签到,获得积分10
8秒前
Capedem完成签到 ,获得积分10
8秒前
8秒前
火星上的百川完成签到,获得积分10
8秒前
甜美的芝发布了新的文献求助20
8秒前
高分求助中
Mass producing individuality 600
Разработка метода ускоренного контроля качества электрохромных устройств 500
A Combined Chronic Toxicity and Carcinogenicity Study of ε-Polylysine in the Rat 400
Advances in Underwater Acoustics, Structural Acoustics, and Computational Methodologies 300
The Framed World: Tourism, Tourists and Photography (New Directions in Tourism Analysis) 1st Edition 200
Graphene Quantum Dots (GQDs): Advances in Research and Applications 200
Advanced Introduction to US Civil Liberties 200
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3825290
求助须知:如何正确求助?哪些是违规求助? 3367618
关于积分的说明 10446647
捐赠科研通 3086928
什么是DOI,文献DOI怎么找? 1698354
邀请新用户注册赠送积分活动 816756
科研通“疑难数据库(出版商)”最低求助积分说明 769937